Brief communication: Breast cancer associated with repeated fluoroscopy
Grundy, G.W.; Uzman, B.G.
Journal of the National Cancer Institute 51(4): 1339-1340
1973
ISSN/ISBN: 0027-8874 PMID: 4745862 Document Number: 65071
Document emailed within 1 workday
Related Documents
Delarue, N.C.; Gale, G.; Ronald, A. 1975: Multiple fluoroscopy of the chest: carcinogenicity for the female breast and implications for breast cancer screening programs Canadian Medical Association Journal 112(12): 1405-1413Boice, J.D.; Monson, R.R. 1977: Breast cancer in women after repeated fluoroscopic examinations of the chest Journal of the National Cancer Institute 59(3): 823-832
Boschat, J.; Daoulas, M.; Etienne, Y.; Ollivier, J.P.; Blanc, J.J.; Bellet, M.; Penther, P. 1982: Cineangiography and fluoroscopy in evaluating segmental left ventricular contractility in coronary artery disease: a critical study of fluoroscopy Annales de Cardiologie et d'Angeiologie 31(6): 453-456
Dorosevich, A.E.; Golubev, O.A.; Abrosimov, S.Iu.; Bekhtereva, I.A. 1998: The role of cell communication in the pathogenesis of breast cancer Voprosy Onkologii 44(4): 398-402
Cvijović, J.; Milica Kostić-Stanković; Krstić, G.; Stojanović, L. 2016: Marketing communication in the area of breast and cervical cancer prevention Vojnosanitetski Pregled 73(6): 544-552
Eskelinen, M.; Korhonen, R.; Selander, T.; Ollonen, P. 2015: Emotional personality/proximity versus emotional authenticity in patient-physician communication in healthy study participants, and in patients with benign breast disease, and breast cancer: a prospective case-control study in Finland Anticancer Research 35(3): 1627-1633
Taguchi, K.; Iihara, H.; Ishihara, M.; Komori, Y.; Tanizawa, K.; Matsuura, K.; Itoh, Y. 2009: Comparison of antiemetic efficacy between single and repeated treatments with a 5-HT3 receptor antagonist in breast cancer patients with high-risk emetogenic chemotherapy Anticancer Research 29(5): 1721-1725
Lipkus, I.M.; Iden, D.; Terrenoire, J.; Feaganes, J.R. 1999: Relationships among breast cancer concern, risk perceptions, and interest in genetic testing for breast cancer susceptibility among African-American women with and without a family history of breast cancer Cancer Epidemiology Biomarkers and Prevention: a Publication of the American Association for Cancer Research Cosponsored by the American Society of Preventive Oncology 8(6): 533-539
Clayton, M.F.; Dudley, W.N. 2009: Patient-centered communication during oncology follow-up visits for breast cancer survivors: content and temporal structure Oncology Nursing Forum 36(2): E68-E79
Blokhina, N.G.; Shirin, D.F.; Khaĭlenko, V.A.; Zaslavskiĭ, B.Iu.; Mestechkina, N.M. 1984: Possibilities of using the method of distribution of total blood proteins in biphasic polymer systems in the diagnosis of mastopathy and breast cancer (preliminary communication) Vestnik Akademii Meditsinskikh Nauk SSSR 1984(5): 35-39
1997: Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases. Breast Cancer Linkage Consortium Lancet 349(9064): 1505-1510
Kauffmann, R.; Bitz, C.; Clark, K.; Loscalzo, M.; Kruper, L.; Vito, C. 2016: Addressing psychosocial needs of partners of breast cancer patients: a pilot program using social workers to improve communication and psychosocial support Supportive Care in Cancer: Official Journal of the Multinational Association of Supportive Care in Cancer 24(1): 61-65
Butler, M.; Paisley, W. 1976: The potential of mass communication and inter personal communication for cancer control Cullen, J W , B H Fox And R N Isom (Ed ) Cancer: The Behavioral Dimensions Conference on Cancer Control And The Behavioral Sciences San Antonio, Tex , Usa, Jan 1975 Xvi+390p Illus Raven Press: New York, N Y , Usa ISBN 0-89004-104-0: 205-229
Cowan, D.H.; Laidlaw, J.C. 1993: A strategy to improve communication between health care professionals and people living with cancer. I. Improvement of teaching and assessment of doctor-patient communication in Canadian medical schools Journal of Cancer Education: the Official Journal of the American Association for Cancer Education 8(2): 109-117
Reiner, A.S.; Sisti, J.; John, E.M.; Lynch, C.F.; Brooks, J.D.; Mellemkjær, L.; Boice, J.D.; Knight, J.A.; Concannon, P.; Capanu, M.; Tischkowitz, M.; Robson, M.; Liang, X.; Woods, M.; Conti, D.V.; Duggan, D.; Shore, R.; Stram, D.O.; Thomas, D.C.; Malone, K.E.; Bernstein, L.; Bernstein, J.L. 2018: Breast Cancer Family History and Contralateral Breast Cancer Risk in Young Women: An Update From the Women's Environmental Cancer and Radiation Epidemiology Study Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 36(15): 1513-1520
Nabholtz, J.M.; Lindsay, M.A.; Hugh, J.; Mackey, J.; Smylie, M.; Au, H.J.; Tonkin, K.; Allen, M. 1999: The academic global virtual concept in clinical cancer research and its application to breast cancer: The Breast Cancer International Research Group Seminars in Oncology 26(3 Suppl. 8): 4-8
Albeshan, S.M.; Hossain, S.Z.; Mackey, M.G.; Brennan, P.C. 2020: Can Breast Self-examination and Clinical Breast Examination Along with Increasing Breast Awareness Facilitate Earlier Detection of Breast Cancer in Populations with Advanced Stages at Diagnosis? Clinical Breast Cancer 20(3): 194-200
Siefert, H.M.; Maruhn, D.; Scholl, H. 1986: Pharmacokinetics of ciprofloxacin. 2nd communication: distribution to and elimination from tissues and organs following single or repeated administration of [14C]ciprofloxacin in albino rats Arzneimittel-Forschung 36(10): 1503-1510
Stamatovic, L.; Susnjar, S.; Gavrilovic, D.; Minic, I.; Ursulovic, T.; Dzodic, R. 2018: The influence of breast cancer subtypes on the response to anthracycline neoadjuvant chemotherapy in locally advanced breast cancer patients Journal of Buon: Official Journal of the Balkan Union of Oncology 23(5): 1273-1280
Rosenberg, L.; Palmer, J.R.; Shapiro, S. 1992: Oestrogen replacement therapy and breast cancer Results from the Slone Epidemiology Units Toronto Breast Cancer Study Mann, R D Hormone replacement therapy and breast cancer risk : 253-264